Accueil / Nouvelles et Évènements / Salle des médias
Salle des médias
Contact pour les médias
Si vous êtes journaliste, nos experts en relations avec les médias peuvent:
- Fournir des informations sur GlycoNet et ses activités
- Planifiez des entretiens avec nos porte-parole et experts
- Vous mettre en contact avec des entrepreneurs associés au Réseau
Relations avec les médias
GlycoNet dans l’Actualité
On Global Edmonton’s Health Matters segment, GlycoNet CEO Elizabeth Nanak and 48Hour Discovery CEO Ratmir Derda shared how glycomics research is driving new health solutions & speeding up drug discovery (March 23, 2022).
GlycoNet Researchers in the News
Medicago’s homegrown, plant-based COVID-19 vaccine approved by Health Canada
“We will, in the next several months, know how well our vaccine did against Omicron,” the company’s medical officer, Dr. Brian Ward, told CBC News, citing ongoing company trials. (CBC News, February 2022)
How a protein in our brains could protect us from Alzheimer
Dr. Matthew Macauley talked to CBC Radio Active about a promising promising development in the battle against the disease (CBC Radio Active with Adrienne Pan, December 2019)
UBC research brings us one step closer to universal blood
UBC researchers have found what could be a game changer for blood donation.They have identified gut enzymes that can turn any type of blood into the universally usable type “O.” (Global News, June 2019)
Solving the superbug: McGill team dedicated to fighting human health threat
Dr. Don Sheppard, co-director and founder of MI4 spoke to CTV Montreal about the initiative and its goals to control and evolve around Superbugs. (CTV Montreal, May 2019)
Chargement de glucides: les professeurs de sciences de la région d'Edmonton retournent à l'école pour suivre des cours sur les glucides
High school teachers were on the other side of the classroom with the chance to play with the research on carbohydrates. (Edmonton Journal, December 2018)
Made to measure sugar-like molecule could improve cancer-fighting antibodies
Dr. Robert Britton has embarked on an ambitious project to develop carbohydrate mimics to assist cancer therapies. (Medical Xpress, May 2018)
U of A professors research link between proteins and Alzheimer’s
A protein found in the human brain may be the key to treating Alzheimer’s disease. (Global News, January 2018)
CKUA Innovation Anthology: Interview with Dr. Karla Williams
A simple blood test to detect aggressive prostate cancer is on the path to commercialization.
CKUA Innovation Anthology: Interview with Dr. Stephen Withers
A compound in the plant holds the key to treating blood spikes in diabetic patients. (Photo source: Source: MSL)
CKUA Innovation Anthnology: Interview with Dr. Jason Acker and Dr. Robert Ben
Researchers found molecules to prevent ice crystals from forming, thus protecting cells from damage during cryopreservation.
Edmonton startup wants to put Alberta at epicentre of molecular discoveries
Biochemist and 48Hour Discovery founder Ratmir Derda hopes the Edmonton-based company will become “the next molecular Google.” (Edmonton Journal, December 2017)
2017 ASTech Award Winner: Science, Dr. Lori J. West
First-of-its-kind procedure opens door for hundreds more
Enzymes that make superbugs vulnerable
GlycoNet researchers discover enzymes that can aid pulmonary infections and chronic wounds. (Nature Podcast)
Canadian breakthrough against a deadly fungus
Canadian researchers have discovered the defence mechanism of the often deadly fungus and are developing ways to fight it by using its own defences against it. (Radio Canada International, November 2015)
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tél.: 780-492-6204
Téléc.: 780-492-4147
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.
French 
English 